97 related articles for article (PubMed ID: 8323416)
1. Effect of oxodipine, a novel dihydropyridine calcium channel blocker, in neurogenic hypertensive dogs.
Montastruc P; Montastruc JL; Dubreuil J; Galiano A
Arch Int Pharmacodyn Ther; 1993; 321():57-62. PubMed ID: 8323416
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular profile of oxodipine, a novel dihydropyridine calcium channel blocker, in anesthetized open-chest dogs: a comparison with nitrendipine.
Alloui A; Talmant JM; Duchêne-Marullaz P
Arch Int Pharmacodyn Ther; 1991; 313():63-75. PubMed ID: 1816765
[TBL] [Abstract][Full Text] [Related]
3. Chronotropic effects of azelnidipine, a slow- and long-acting dihydropyridine-type calcium channel blocker, in anesthetized dogs: a comparison with amlodipine.
Fujisawa M; Yorikane R; Chiba S; Koike H
J Cardiovasc Pharmacol; 2009 Apr; 53(4):325-32. PubMed ID: 19295444
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of OPC-13340, a potent, long-acting 1,4-dihydropyridine calcium channel blocker, in dogs.
Mori T; Nakayama N; Ohura M; Ikezono K; Kinoshita S; Kamata M; Hosokawa T; Yamashita S; Yabuuchi Y
Arch Int Pharmacodyn Ther; 1993; 321():41-56. PubMed ID: 8323415
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive effects of lercanidipine in experimental hypertensive rats and dogs.
Sironi G; Montagna E; Greto L; Bianchi G; Leonardi A; Testa R
Arzneimittelforschung; 1996 Feb; 46(2):145-52. PubMed ID: 8720303
[TBL] [Abstract][Full Text] [Related]
6. Effects of calcium entry blockers on blood pressure and heart rate in neurogenic hypertensive dogs.
Montastruc P; Valet P; Dang Tran L; Gaillard G; Montastruc JL
Fundam Clin Pharmacol; 1987; 1(2):85-94. PubMed ID: 3500100
[TBL] [Abstract][Full Text] [Related]
7. Effects of four calcium channel blockers on central cardiovascular control.
Montastruc JL; Damase-Michel C; Dang-Tran L; Montastruc P
Arch Int Pharmacodyn Ther; 1989; 297():112-9. PubMed ID: 2730230
[TBL] [Abstract][Full Text] [Related]
8. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: alterations in baroreflex sensitivity.
Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
J Pharmacol Exp Ther; 1984 Aug; 230(2):376-82. PubMed ID: 6747841
[TBL] [Abstract][Full Text] [Related]
9. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive activity of a new calcium channel blocker LF 2.0254, in spontaneously hypertensive rats: a comparison with nifedipine and nicardipine.
Pruneau D; Brown NL
Arch Int Pharmacodyn Ther; 1988; 295():109-24. PubMed ID: 2977540
[TBL] [Abstract][Full Text] [Related]
11. Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure.
Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Fukuda T; Numao T; Shimada K; Kario K
J Cardiovasc Pharmacol; 2007 Jun; 49(6):394-400. PubMed ID: 17577104
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure.
Saitoh C; Momose K; Tanaka H; Sato S; Taguchi K; Saitoh M; Maehara J; Asano M; Usuda S
Arzneimittelforschung; 1998 Feb; 48(2):125-32. PubMed ID: 9541721
[TBL] [Abstract][Full Text] [Related]
13. Comparison of calcium channel inhibitors on vagal heart rate responses elicited by arterial baroreceptor reflexes in anesthetized dogs.
Taylor DG; Kowalski TE
J Pharmacol Exp Ther; 1984 Feb; 228(2):491-9. PubMed ID: 6694122
[TBL] [Abstract][Full Text] [Related]
14. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
[TBL] [Abstract][Full Text] [Related]
15. Effects of benidipine hydrochloride on 24-hour blood pressure and blood pressure response to mental stress in elderly patients with essential hypertension.
Muneta S; Kohara K; Hiwada K
Int J Clin Pharmacol Ther; 1999 Mar; 37(3):141-7. PubMed ID: 10190762
[TBL] [Abstract][Full Text] [Related]
16. Cardiac effects of L/N-type Ca2+ channel blocker cilnidipine in anesthetized dogs.
Takahara A; Iwasaki H; Nakamura Y; Sugiyama A
Eur J Pharmacol; 2007 Jun; 565(1-3):166-70. PubMed ID: 17445796
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
Kanda A; Haruno A; Miyake H; Nagasaka M
J Cardiovasc Pharmacol; 1992; 20(5):723-30. PubMed ID: 1280733
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
[TBL] [Abstract][Full Text] [Related]
19. Cilnidipine inhibits the sympathetic nerve activity and improves baroreflex sensitivity in patients with hypertension.
Kishi T; Hirooka Y; Konno S; Sunagawa K
Clin Exp Hypertens; 2009 May; 31(3):241-9. PubMed ID: 19387900
[TBL] [Abstract][Full Text] [Related]
20. Effects of CS-905, a novel dihydropyridine calcium channel blocker, on arterial pressure, renal excretory function, and inner medullary blood flow in the rat.
Yagil Y; Miyamoto M; Frasier L; Oizumi K; Koike H
Am J Hypertens; 1994 Jul; 7(7 Pt 1):637-46. PubMed ID: 7946166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
